Dyne was founded with a singular focus: to deliver life-transforming therapies for people living with serious muscle diseases. We are utilizing our proprietary FORCE™ platform to overcome limitations of muscle tissue delivery and advance modern oligonucleotide therapeutic candidates. We have assembled an exceptional team with deep experience in muscle disease, rare disorders, drug development and manufacturing and commercialization of novel therapeutics. We have also established a scientific advisory board comprised of leading experts in the fields of muscle disease drug discovery and development and nucleic acid therapeutics, who share our mission.
Because together, we are stronger.
John Cox, MBA
President and Chief Executive Officer
Doug Kerr, M.D., Ph.D., MBA
Chief Medical Officer
Johanna Friedl-Naderer
Chief Commercial Officer
Oxana Beskrovnaya, Ph.D.
Chief Scientific Officer
Ashish Dugar, Ph.D., MBA
Chief Medical Affairs Officer
Debra Feldman
Chief Regulatory Affairs Officer
Lucia Celona
Chief Human Resources Officer
John Najim, MBA
Chief Technical Officer
Rick Scalzo, MBA
Senior Vice President, Head of Finance & Administration
Amy Reilly
Senior Vice President, Head of Corporate Communications & Investor Relations
Daniel Wilson
Senior Vice President, Head of Legal
Wildon Farwell, M.D., MPH
Dyne Medical Advisor
Board of directors
Jason Rhodes
Chairman
John Cox
Ed Hurwitz
Carlo Incerti, M.D.
Dirk Kersten
David Lubner
Catherine Stehman-Breen
Scientific advisory board
Sudhir Agrawal, D.Phil.
Nancy Andrews, M.D., Ph.D.
Louis Kunkel, Ph.D.
Francesco Muntoni, FRCPCH, FMedSci
Jeffrey Statland, M.D.
Charles Thornton, M.D.
Contact us
For general inquiries, email us at info@dyne-tx.com.
To learn more about partnerships or working together, email us at partnerships@dyne-tx.com.
For investor and media inquiries, email us at ir@dyne-tx.com
Follow us on
Offices
1560 Trapelo Road
Waltham, MA 02451
Phone: 781.786.8230
Fax: 781.786.8866
